Commodore Capital’s Entera Bio ENTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21.4M Buy
+7,352,941
New +$19.6M 1.66% 19

Other funds holding ENTX

Commodore Capital's ENTX Position: Q3 2026 in Review

Commodore Capital opened a new position in Entera Bio (ENTX) in Q3 2026: 7,352,941 shares worth $21.4M. The stake represents 1.66% of the portfolio and ranks #19 among its holdings.

45 funds tracked by Wall St. Rank hold ENTX as of Q3 2026.

  • Commodore Capital held 7,352,941 shares of Entera Bio worth $21.4M as of Q3 2026.
  • Entera Bio was a new Commodore Capital position in Q3 2026.
  • Entera Bio made up 1.66% of Commodore Capital's portfolio in Q3 2026, its #19 holding.
  • 45 funds tracked by Wall St. Rank held Entera Bio as of Q3 2026.

Based on Commodore Capital's 13F filing for Q3 2026, filed 16 Nov 2026.